Neural networks in the prediction of survival in patients with colorectal cancer

Clinical Colorectal Cancer

Volumn 2, Issue 4, 2003, Pages 239-244

  Grumett, Simon ^a   Snow, Pete ^b   Kerr, David ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Xaim Inc   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Dukes staging; Logistic regression; Multilayer perception; Prognosis; Risk factors; TNM staging

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; METHODOLOGY; OUTCOMES RESEARCH; PATHOGENICITY; PHENOTYPE; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SAMPLE SIZE; STATISTICAL MODEL;

EID: 0037302384     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2003.n.005     Document Type: Article

References (15)

1. Office for National Statistics. Mortality Statistics: Cause, England and Wales 1999. London, UK: Office for National Statistics; 2000.
2. Midgley RS, Kerr DJ. Adjuvant treatment of colorectal cancer. Cancer Treat Rev 1997; 23:135-152.
3. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995; 345:939-944.
4. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35:323-332.
5. Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1865-1878.
6. McLeod HL, Murray GI. Tumour markers of prognosis in colorectal cancer. Br J Cancer 1999; 79:191-203.
7. Dayhoff JE, DeLeo JM. Artificial neural networks: opening the black box. Cancer 2001; 91 (suppl):1615-1635.
8. DeLeo JM. The fuzzy receiver operating characteristic function and medical decisions with uncertainty. In: Proceedings of the First International Symposium on Uncertainty Modeling and Analysis. Los Alamitos, CA: IEEE Computer Society Press; 1990:694-699.
9. Mehrotra K, Mohan CK, Ranka S, et al. Elements of Artificial Neural Networks. Cambridge, MA: MIT Press; 1996.
10. Bishop CM. Neural Networks for Pattern Recognition. London, UK: Oxford University Press; 1996.
11. Keller T, Bitterlich N, Hilfenhaus S, et al. Tumour markers in the diagnosis of bronchial carcinoma: new options using fuzzy logic-based tumour marker profiles. J Cancer Res Clin Oncol 1998; 124:565-574.
12. Petersen VC, Baxter KJ, Love SB, et al. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002; 51:65-69.
13. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996; 28:543-548.
14. Altman DG. Systematic reviews of evaluations of prognostic variables. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-Analysis in Context. London, UK: BMJ Books; 2001:228-247.
15. Sargent DJ. Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer 2001; 91(suppl):1636-1642.